Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fever in the Emergency Department Predicts Survival of Patients With Severe Sepsis and Septic Shock Admitted to the ICU.
Sundén-Cullberg J, Rylance R, Svefors J, Norrby-Teglund A, Björk J, Inghammar M. Sundén-Cullberg J, et al. Crit Care Med. 2017 Apr;45(4):591-599. doi: 10.1097/CCM.0000000000002249. Crit Care Med. 2017. PMID: 28141683
Culture-negative severe septic shock: indications for streptococcal aetiology based on plasma antibodies and superantigenic activity.
Norrby-Teglund A, Berdal JE. Norrby-Teglund A, et al. Scand J Infect Dis. 2001;33(8):634-7. doi: 10.1080/00365540110026809. Scand J Infect Dis. 2001. PMID: 11525365
Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.
Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A; StreptIg Study Group. Darenberg J, et al. Clin Infect Dis. 2003 Aug 1;37(3):333-40. doi: 10.1086/376630. Epub 2003 Jul 17. Clin Infect Dis. 2003. PMID: 12884156 Clinical Trial.
Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.
Sundén-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ. Sundén-Cullberg J, et al. Crit Care Med. 2005 Mar;33(3):564-73. doi: 10.1097/01.ccm.0000155991.88802.4d. Crit Care Med. 2005. PMID: 15753748
The role of high mobility group box-1 protein in severe sepsis.
Sunden-Cullberg J, Norrby-Teglund A, Treutiger CJ. Sunden-Cullberg J, et al. Curr Opin Infect Dis. 2006 Jun;19(3):231-6. doi: 10.1097/01.qco.0000224816.96986.67. Curr Opin Infect Dis. 2006. PMID: 16645483 Review.
Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.
Sundén-Cullberg J, Nyström T, Lee ML, Mullins GE, Tokics L, Andersson J, Norrby-Teglund A, Treutiger CJ. Sundén-Cullberg J, et al. Crit Care Med. 2007 Jun;35(6):1536-42. doi: 10.1097/01.CCM.0000266536.14736.03. Crit Care Med. 2007. PMID: 17452927
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
Giamarellos-Bourboulis EJ, Norrby-Teglund A, Mylona V, Savva A, Tsangaris I, Dimopoulou I, Mouktaroudi M, Raftogiannis M, Georgitsi M, Linnér A, Adamis G, Antonopoulou A, Apostolidou E, Chrisofos M, Katsenos C, Koutelidakis I, Kotzampassi K, Koratzanis G, Koupetori M, Kritselis I, Lymberopoulou K, Mandragos K, Marioli A, Sundén-Cullberg J, Mega A, Prekates A, Routsi C, Gogos C, Treutiger CJ, Armaganidis A, Dimopoulos G. Giamarellos-Bourboulis EJ, et al. Crit Care. 2012 Aug 8;16(4):R149. doi: 10.1186/cc11463. Crit Care. 2012. PMID: 22873681 Free PMC article.
Short- and long-term mortality in severe sepsis/septic shock in a setting with low antibiotic resistance: a prospective observational study in a Swedish university hospital.
Linnér A, Sundén-Cullberg J, Johansson L, Hjelmqvist H, Norrby-Teglund A, Treutiger CJ. Linnér A, et al. Front Public Health. 2013 Nov 15;1:51. doi: 10.3389/fpubh.2013.00051. eCollection 2013. Front Public Health. 2013. PMID: 24350220 Free PMC article.
Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund A. Linnér A, et al. Clin Infect Dis. 2014 Sep 15;59(6):851-7. doi: 10.1093/cid/ciu449. Epub 2014 Jun 13. Clin Infect Dis. 2014. PMID: 24928291
Differential neutrophil responses to bacterial stimuli: Streptococcal strains are potent inducers of heparin-binding protein and resistin-release.
Snäll J, Linnér A, Uhlmann J, Siemens N, Ibold H, Janos M, Linder A, Kreikemeyer B, Herwald H, Johansson L, Norrby-Teglund A. Snäll J, et al. Sci Rep. 2016 Feb 18;6:21288. doi: 10.1038/srep21288. Sci Rep. 2016. PMID: 26887258 Free PMC article. Clinical Trial.
122 results
Jump to page
Feedback